WHO ICTRP trial
Mesenchymal stem cells after acute myocardial infarction.
NL-OMON24674 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON24674 |
|---|---|
| Public title | Mesenchymal stem cells after acute myocardial infarction. |
| Scientific title | Autologous bone marrow-derived in vitro expanded mesenchymal stem cell transplantation in patients with an acute myocardial infarction treated by successful primary percutaneous transluminal coronary angioplasty A safety and feasibility study |
| Primary sponsor | Investigator-initiated study. Principal investigator: dr. D.E. Atsma |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Acute myocardial infarction |
| Interventions | - Bone marrow cell aspiration from the iliac crest - Ex-vivo expansion of mesenchymal stem cells - Intramyocardial injection (by catheterization) of expanded mesenchymal stem cells |
| Registration date | Nov 26, 2008 |
| Target size | 48 |
| Secondary IDs | NL1483;NTR1553; : P.05.179;ISRCTN wordt niet meer aangevraagd |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: